Compumedics Ltd
ASX:CMP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.245
0.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Compumedics Ltd
Research & Development
Compumedics Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Compumedics Ltd
ASX:CMP
|
Research & Development
-AU$1.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
Somnomed Ltd
ASX:SOM
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Research & Development
-AU$443.9k
|
CAGR 3-Years
6%
|
CAGR 5-Years
37%
|
CAGR 10-Years
-36%
|
|
|
Cochlear Ltd
ASX:COH
|
Research & Development
-AU$291.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Research & Development
-AU$4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Compumedics Ltd
Glance View
Compumedics Ltd. is engaged in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. The firm is engaged in development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The firm sells all its product offerings, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultra-sonic blood-flow systems, supplies and technical service and support. The firm sell its products throughout America’s, Australia and Asia Pacific, and Europe and the Middle East regions. Its United States business also includes sleep diagnostic services business. The firm product includes ONsight A.V.S., Grael PSG, Grael LT EEG System, Siesta 802, Grael 4K PSG:EEG, Grael 4K-EEG, Neuvo 64-512 Channel LTM EEG and CURRY. The Company’s subsidiaries include Compumedics USA Ltd, DWL USA Inc., Compumedics USA Inc, Compumedics Telemed Pty Ltd, Compumedics Medical Innovation Pty Ltd, Compumedics Cardiology Pty Ltd.
See Also
What is Compumedics Ltd's Research & Development?
Research & Development
-1.3m
AUD
Based on the financial report for Jun 30, 2025, Compumedics Ltd's Research & Development amounts to -1.3m AUD.
What is Compumedics Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
12%
Over the last year, the Research & Development growth was 77%. The average annual Research & Development growth rates for Compumedics Ltd have been 31% over the past three years , 19% over the past five years , and 12% over the past ten years .